Literature DB >> 10802943

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action.

M Lübbert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10802943     DOI： 10.1007/978-3-642-59696-4_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  36 in total

Review 1.  DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.

Authors:  Jian Tajbakhsh
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

2.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Authors:  Wenli Liu; Hyun Woo Lee; Yueqin Liu; Ruihong Wang; Griffin P Rodgers
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

Review 3.  Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings.

Authors:  Romulo Martin Brena; Tim Hui-Ming Huang; Christoph Plass
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

4.  DNA Methylation Inhibitor Zebularine Confers Stroke Protection in Ischemic Rats.

Authors:  Hua Dock; Annette Theodorsson; Elvar Theodorsson
Journal:  Transl Stroke Res       Date:  2015-04-01       Impact factor: 6.829

Review 5.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 6.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 7.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

8.  Demethylating drugs as novel analgesics for cancer pain.

Authors:  Chi T Viet; Dongmin Dang; Yi Ye; Kentaro Ono; Ronald R Campbell; Brian L Schmidt
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

9.  Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.

Authors:  Jonathan C Cheng; Daniel J Weisenberger; Felicidad A Gonzales; Gangning Liang; Guo-Liang Xu; Ye-Guang Hu; Victor E Marquez; Peter A Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 10.  Myelodysplastic syndrome: an update on diagnosis and therapy.

Authors:  Ahrin Koppel; Gary Schiller
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.